Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
1,890,639
-
Share change
-
+231,474
-
Total reported value
-
$46,133,000
-
Price per share
-
$24.41
-
Number of holders
-
10
-
Value change
-
+$5,629,927
-
Number of buys
-
4
-
Number of sells
-
4
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2018
As of 31 Mar 2018,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,890,639 shares.
The largest 10 holders included
PARAMETRIC PORTFOLIO ASSOCIATES LLC, World Asset Management Inc, Pinnacle Wealth Planning Services, Inc., QUADRANT CAPITAL GROUP LLC, GLENMEDE TRUST CO NA, Hexavest Inc., Private Capital Group, LLC, Geneos Wealth Management Inc., Gemmer Asset Management LLC, and FTB Advisors, Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.